Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Spectroscopy,Pollution,Radiology, Nuclear Medicine and imaging,Nuclear Energy and Engineering,Analytical Chemistry
Reference43 articles.
1. Kristensen JL, Herth MM (2017) In vivo imaging in drug discovery. In: Stromgaard K, Krogsgaard-Larsen P, Madsen U (eds) Textbook of drug design and discovery, 5th edn. CRC Press, Copenhagen
2. Piel M, Vernaleken I, Rösch F (2014) Positron emission tomography in CNS drug discovery and drug monitoring. J Med Chem 57:9232–9258. https://doi.org/10.1021/jm5001858
3. Miller PW, Long NJ, Vilar R, Gee AD (2008) Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. Angew Chem Int Ed 47:8998–9033. https://doi.org/10.1002/anie.200800222
4. Frank RA, Långström B, Antoni G et al (2007) The imaging continuum: bench to biomarkers to diagnostics. J Label Compd Radiopharm 50:746–769
5. Zhang L, Villalobos A, Beck EM et al (2013) Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand. J Med Chem 56:4568–4579. https://doi.org/10.1021/jm400312y